Clinical Trial Update: Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients [NA]

View source ↗

Summary

A clinical trial update evaluating the Folfox4 chemotherapy regimen to prevent early postoperative recurrence in patients with hepatocellular carcinoma and port…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Guangxi Medical University | Conditions: Carcinoma, Hepatocellular | NA | Status: UNKNOWN